The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The many roles of molecular complexity in drug discovery
Abstract
Molecular complexity is becoming a crucial concept in drug discovery. It has been associated with target selectivity, success in progressing into clinical development and compound safety, among other factors. Multiple metrics have been developed to quantify molecular complexity and explore complexity-property relationships. However, there is no general agreement regarding how to measure this molecular feature. Herein, we have surveyed the many roles of molecular complexity in drug discovery discussing in a critical manner different quantification methods. Through the analysis of various reference compound databases, common pitfalls and workarounds of the quantification of molecular complexity are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among scores developed so far155 the most popular is SA score.156”
From QSAR without borders (2020) · cites this paper as [155]
Citations
Cites
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J. A., & Humblet, C. C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,614
DrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou-Feunang, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,995
DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
Sander, T., Freyss, J., von Korff, M., & Rufener, C. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500588j · Cited by 1,874
Escape from Flatland 2: complexity and promiscuity
Lovering, F. (2012) · MedChemComm · doi:10.1039/c2md20347b · Cited by 1,469
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
Handbook of Olfaction and Gustation
Doty, R. L. (2003) · CRC Press eBooks · doi:10.1201/9780203911457 · Cited by 1,228
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 904
Molecular Similarity in Medicinal Chemistry
Maggiora, G. M., Vogt, M., Stumpfe, D., & Bajorath, J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401411z · Cited by 686
Polypharmacology: drug discovery for the future
Reddy, A. S., & Zhang, S. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.74 · Cited by 498
Duan, J., Dixon, S. L., Lowrie, J. F., & Sherman, W. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.05.008 · Cited by 452
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–181 of 181
Chemoinformatic Resources for Organometallic Drug Discovery
Medina‐Franco, J. L., Cruz-Lemus, Y., & Percastre-Cruz, Y. (2020) · Computational Molecular Bioscience · doi:10.4236/cmb.2020.101001 · Cited by 7
“One of the distinct structural features of organometallic drugs is molecular complexity that is well-known to have a major impact on drug discovery [6].”
BackgroundSelf-citationWang, X., Wang, Y., Zhu, Y., Lei, X., Zhang, M., & Li, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114771 · Cited by 6
Adeoye, M. D., Oyebamiji, A. K., Ashiru, M. A., Adigun, R. A., Olalere, O. H., & Semire, B. (2022) · Eclética Química · doi:10.26850/1678-4618eqj.v47.4.2022.p27-36 · Cited by 6
Crystallization-Enabled Stereoconvergent Michael Additions of β-Keto Esters to Nitroolefins
Sherman, E. R., Cassels, W. R., & Johnson, J. S. (2023) · Organic Letters · doi:10.1021/acs.orglett.3c02799 · Cited by 6
Zhao, Y., Yan, L.-B., Liao, L.-F., Wu, G., Zhong, X., Liang, C., Chen, C.-H., & Mo, D. (2024) · Organic Letters · doi:10.1021/acs.orglett.4c03553 · Cited by 6
Itoh, K., Takashino, A., Ohtsuka, A., Kobe, M., Sawamura, S., Kato, R., Hirayama, S., Karaki, F., Mizuguchi, T., Sato, N., et al. (2020) · ChemPhotoChem · doi:10.1002/cptc.202000004 · Cited by 6
Predictions of Colloidal Molecular Aggregation Using AI/ML Models
Kombo, D. C., Stepp, J. D., Lim, S., Elshorst, B., Li, Y., Cato, L., Shomali, M., Fink, D. M., & LaMarche, M. J. (2024) · ACS Omega · doi:10.1021/acsomega.4c02886 · Cited by 6
Runikhina, S. A., Tsygankov, A. A., Afanasyev, O. I., & Chusov, D. A. (2023) · Mendeleev Communications · doi:10.1016/j.mencom.2023.01.005 · Cited by 5
Targeting σ2R/TMEM97 with novel aminotetralins
Wood, M. D., Sahn, J. J., & Martin, S. F. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114696 · Cited by 5
Malik, M. S., Adil, S. F., Seddigi, Z. S., Morad, M. H., Jassas, R. S., Thagafi, I. I., Altass, H. M., Jamal, Q. M. S., Riyaz, S., Alsantali, R. I., et al. (2021) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2021.101226 · Cited by 5
“The conformational flexibility, molecular complexity and shape index were calculated utilising OSIRIS property explorer tool [DataWarrior] [23–25].”
Oulladji, L., Saadallah, M., Guellil, Z., Abbad, H., & Bekhti, H. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108532 · Cited by 5
Conboy, Ó., Rushworth, E. Q., Taylor, C. J., Levy, C., Ortmayer, M., Whitehead, G. F. S., Yen, A., Romano, C., Green, A. P., & Procter, D. J. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c16261 · Cited by 4
Kumar, D. S., Karthikeyan, D., & Roy, B. (2022) · Asian Journal of Chemistry · doi:10.14233/ajchem.2022.23521 · Cited by 4
Tandi, M., Tripathi, N., Gaur, A., Gopal, B., & Sundriyal, S. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10588-1 · Cited by 4
“However, it must be noted that molecular complexity may be calculated in several ways [76, 77].”
Srikanth, G., Ravi, A., Sebastian, A., Khanfar, M. A., Abu‐Yousef, I. A., Majdalawieh, A. F., El–Gamal, M. I., Alkubaisi, B. O., Shahin, A. I., Joseph, J., et al. (2023) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.2c02653 · Cited by 4
Sinha, P. K., Reddy, M. S., Behera, P. C., Nanubolu, J. B., & Suresh, S. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202300805 · Cited by 3
Navigating the Chemical Space of ENR Inhibitors: A Comprehensive Analysis
Kuralt, V., & Frlan, R. (2024) · Antibiotics · doi:10.3390/antibiotics13030252 · Cited by 3
Kumar, D. S., Karthikeyan, D., & Roy, B. (2022) · Asian Journal of Chemistry · doi:10.14233/ajchem.2022.23624 · Cited by 3
Rasheed, S. H., Vakkalagadda, R. K., Mustak, S., & Sen, S. (2023) · Pharmacognosy Research · doi:10.5530/pres.16.1.21 · Cited by 3
Singh, S., Zeh, G., Freiherr, J., Bauer, T., Turkmen, I., & Grasskamp, A. T. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00835-y · Cited by 3
“Molecular complexity, however, is a complex topic which is not in the current scope of work, but we calculate the fraction of chiral centers [56] (FCC) to gain insight into the two datasets.”
BackgroundDiscovery of RMC-6291, a potent, orally bioavailable, covalent RAS(ON) G12C selective inhibitor
Cregg, J., Pota, K., Gill, A. L., & Koltun, E. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21861-3.00006-1 · Cited by 4
Qaoud, M. T., Çapan, İ., Saydam, S., & Servi, S. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144297 · Cited by 2
Marbán‐González, A., & Medina‐Franco, J. L. (2025) · Molecular Informatics · doi:10.1002/minf.70015 · Cited by 4
“…with molecular size [59], molecular complexity which is related to the number to ster-eocenters, fraction of sp 3 carbon (CSP3 fraction), selectivity and promiscuity [60] had relative high mean value of x = 0.76 compared with x = 0.69 of FDA-approved drugs retrieved from DrugBank (2025-01-14) [61].”
InfluentialSelf-citationXie, C., Liu, C., & Ma, D. (2026) · Organic Letters · doi:10.1021/acs.orglett.6c00666 · Cited by 2
Computational design of rasagiline derivatives: Searching for enhanced antioxidant capability
Reina, M., Guzmán‐López, E. G., & Galano, A. (2022) · International Journal of Quantum Chemistry · doi:10.1002/qua.27011 · Cited by 3
Past, Present, and Future: A Changing Paradigm for Process Chemistry
Studley, J. R. (2022) · ACS symposium series · doi:10.1021/bk-2022-1423.ch009 · Cited by 2
The Evolution of Flow Chemistry: An Opinion on Factors Driving Innovation
Bourne, S. L., Amann, F., & Ley, S. V. (2023) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2023.288 · Cited by 2
N-Ylide Mediated Synthesis and Resolution of a Chiral Pyrimidinyl Cyclopropane Carboxylic Acid
Fray, M. J., Fink, S. J., Han, X., Papaioannou, N., Rennhack, A., & Zou, L. (2023) · Organic Process Research & Development · doi:10.1021/acs.oprd.3c00175 · Cited by 2
Zhang, X., Zhang, J.-Q., Sun, Z., Shan, H.-M., Su, J., Ma, X., Su, G., Xu, L., & Mo, D. (2024) · Angewandte Chemie · doi:10.1002/ange.202420390 · Cited by 2
Alonso, F., Quezada, M. J., Gola, G. F., Richmond, V., Cabrera, G. M., Barquero, A. A., & Ramirez, J. A. (2018) · ChemMedChem · doi:10.1002/cmdc.201800295 · Cited by 2
Sanford, A. B., Tollefson, E. J., & Jarvo, E. R. (2019) · Israel Journal of Chemistry · doi:10.1002/ijch.201900071 · Cited by 2
Descubrimiento de fármacos basado en imagenología de células vivas
Hernández-Cuellar, C. E., Martinez, E., & Gallego-Gómez, J. C. (2020) · Revista Colombiana de Ciencias Químico Farmacéuticas · doi:10.15446/rcciquifa.v49n1.87026 · Cited by 2
“Estas interacciones son fundamentales para otorgar actividad y selectividad al compuesto [27].”
BackgroundReddy, D. S., Novitskiy, I. M., & Kutateladze, A. G. (2021) · Angewandte Chemie · doi:10.1002/ange.202112573 · Cited by 2
Kalpana, K., Syed, R., Saranya, J., Rafi, M., & Kiran, B. R. (2021) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428021090153 · Cited by 2
Discovery and development of lead compounds from natural sources using computational approaches
Medina‐Franco, J. L., Flores‐Padilla, E. A., & Chávez‐Hernández, A. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85542-6.00009-3 · Cited by 2
Self-citationSynthetic Matching of Complex Monoterpene Indole Alkaloid Chemical Space
Xie, J., Pahl, A., Krzyzanowski, A., Krupp, A., Liu, J., Koska, S., Schölermann, B., Zhang, R., Bonowski, J., Sievers, S., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202310222 · Cited by 2
An isatin aldol adduct as a precursor to α,α’-difunctionalized methyl vinyl ketones
Jha, A. K., Deeksha, Inani, H., & Easwar, S. (2022) · Results in Chemistry · doi:10.1016/j.rechem.2022.100339 · Cited by 1
Markovnikova, A. I., Likhanov, M. V., & Kurushkin, M. (2024) · Perspectives of science and education · doi:10.32744/pse.2024.3.37 · Cited by 1
“To date, several different metrics have been proposed to assess molecular complexity, for example: topological and physicochemical descriptors, substructure-based approaches, graph-theoretical methods [33].”
BackgroundItoh, K., Nakahara, H., Takashino, A., Hara, A., Katsuno, A., Abe, Y., Mizuguchi, T., Karaki, F., Hirayama, S., Nagai, K., et al. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00599f · Cited by 1
Accelerating Drug Discovery through Knowledge Sharing
McAtee, R. C. (2026) · ChemMedChem · doi:10.1002/cmdc.202500927 · Cited by 1
Gorla, M. R., & Sarma, M. (2022) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428022040157 · Cited by 1
Molecular Complexity for Chemical Reactions
von Korff, M., & Sander, T. (2023) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2023.258 · Cited by 1
Rasheed, S. H., Mustak, S., Mohanty, C., Vakkalagadda, R. K., & Sen, S. (2024) · Asian Journal of Chemistry · doi:10.14233/ajchem.2024.31671 · Cited by 1
Sen, S., Roy, B., Kannappan, N., Zoghebi, K. A., Albratty, M., Alhazmi, H. A., Najmi, A., & Alam, M. S. (2024) · Pharmacognosy Magazine · doi:10.1177/09731296241300873 · Cited by 1
Rapid Assembly of Oxatricyclo[3.2.1.02,7]octanes
Han, Z., Sun, J., Xu, L., Liu, S., & Huang, H. H. (2025) · Synlett · doi:10.1055/a-2538-2942 · Cited by 1
Fujii, H., Hirayama, S., Obayashi, K., Wada, N., Ohyama, K., Fuku, S., Koyano, K., Karaki, F., Itoh, K., & Nagase, H. (2018) · Heterocycles · doi:10.3987/com-18-s(f)65 · Cited by 1
Adigun, T. O., Medayedupin, O. A., Joel, I., Fakolujo, I. Y., Ofeniforo, B., Bankole, F. A., Omoniyi, A. P., Ogunro, O. B., Agunlejika, A., Omoyeni, O. C., et al. (2020) · Preprints.org · doi:10.20944/preprints202012.0797.v1
Chemoinformatic characterization of NAPROC-13: A database for natural product 13C-RMN dereplicationPreprint
Avellaneda-Tamayo, J. F., Agudo-Muñoz, N. A., Sánchez-Galán, J. E., López‐Pérez, J. L., & Medina‐Franco, J. L. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-spksf · Cited by 1
Self-citationFumagalli, F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2019.tde-27052019-111337
Victoria-Muñoz, F., Sánchez‐Cruz, N., Medina‐Franco, J. L., & López-Vallejo, F. (2021) · doi:10.33774/chemrxiv-2021-9fc9m
Self-citationMerging Organocatalysis with Vinylogy – New Opportunities for Asymmetric Synthesis
Curti, C., Sartori, A. M., Battistini, L., & Zanardi, F. (2022) · Asymmetric Organocatalysis · doi:10.1002/9783527832217.ch14
Stereodivergent Transformation of Azepino[3,4,5‐cd]indoles En Route to Nature‐Inspired Scaffolds
Srikanth, G., Ravi, A., Sebastian, A., Joseph, J., Khanfar, M. A., El-Gamal, M. I., Al‐Qawasmeh, R. A., Abu‐Yousef, I. A., Majdalawieh, A. F., & Al‐Tel, T. H. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202201354
Adigun, T. O., Alejolowo, O. O., Sulaiman, F. A., Oluwadare, I. A., Ogunro, O. B., Akinduko, A., Evbuomwan, I. O., Agunlejika, A., Nwonuma, C. O., & Rotimi, D. E. (2024) · International Conference on Science, Engineering and Business for Driving Sustainable Development Goals (SEB4SDG) · doi:10.1109/seb4sdg60871.2024.10630422
An analysis of published synthetic routes, route targets and reaction types (2000 – 2020)Preprint
Howell, G. P., & Genheden, S. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-tj3p3
Torres-Urtizberea, E., Borrell, J. I., de la Bellacasa, R. P., & Estrada‐Tejedor, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094457
Abhilash, Siddiqui, M. A., Jain, R. K., Dayal, S., Kapoor, N., & Mahapatra, R. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.02.673648
Wang, J., Gao, Y., Niu, X.-Z., Song, X., Song, Y., Li, L., & You, Z. (2025) · Organic Letters · doi:10.1021/acs.orglett.5c04428
Bajpai, P. (2026) · Springer briefs in molecular science · doi:10.1007/978-3-032-18003-2_4
Contemporary Applications of Chemical Libraries for Drug Discovery and Methods for Their Synthesis
Hansen, T. N., & Hansen, N. J. V. (2026) · ChemistryEurope · doi:10.1002/ceur.70283
“Most likely this correlation is since F sp3 also correlates with other important properties such as target selectivity and potency [19, 20] as well as physicochemical properties including solubility and logP [21].”
Zhu, J., Benedetti, E., & Micouin, L. (2026) · ChemistryEurope · doi:10.1002/ceur.70321
“Beyond the inherent synthetic difficulty, structural complexity is frequently linked to compelling biological properties [1] or innovative applications in functional materials [2].”
McCormack, S. L., Sherman, E. R., Johnson, J. S., & Sigman, M. S. (2026) · Organic Letters · doi:10.1021/acs.orglett.6c01562
Direct-Injection ESI-MS/MS Method for Studying Fragmentation Pathways of Prospidium Chloride
Kladiev, A. A., Barsegyan, S. S., Akimova, V. D., Esparza, C., & Uspenskaya, E. V. (2026) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v16i7.7869
Asymmetric construction of 2,6-methanobenzo[ g ][1,3]oxazocine scaffolds
Yusuipujiang, N., Xie, C., Tan, J., Zhang, N., Wang, Q., & Ma, D. (2026) · Organic Chemistry Frontiers · doi:10.1039/d6qo00826g
Nzouankeu, J.-B., Mwangi, L., Abega, P., & Dupont, C. (2024) · Pharmacophore · doi:10.51847/bhejqkbzml
Popov, R., Zhang, C., Guénée, L., & Mazet, C. (2026) · JACS Au · doi:10.1021/jacsau.6c01001
Water-Phase Synthesis of 2,5-Methanobenzo[ d ][1,3,6]oxadiazocine with Low Catalyst Loading
Fan, Y., Tan, J., Wang, Q., & Ma, D. (2026) · Organic Letters · doi:10.1021/acs.orglett.6c03712
Li, M., Zhang, H., Fu, R., Mao, L., Zheng, Y., Wang, L.-L., Liu, Y., Zhou, T.-T., Mu, R., Hu, H., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3367-3
Li, Q.-M., Liu, R., Chen, S.-L., Hu, Z.-H., Wang, G., Zhang, W.-B., Liu, Q.-Q., Zhong, X., & Mo, D. (2026) · Organic Letters · doi:10.1021/acs.orglett.6c03373
Eriksen, K., Berg, S., & Dahl, M. (2025) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/43qp6wgo8o
Deekshitha, K., V, Sumithra, S., S. A., & V., V. S. (2026) · Boletim da Sociedade Paranaense de Matemática · doi:10.5269/bspm.79647
BindingDB Entry 50020311: Oxetanes in Drug Discovery Campaigns.
BindingDB (2024) · UC San Diego · doi:10.7270/q2vx0mzp
BindingDB Entry 50019660: Targeting σ
BindingDB (2024) · UC San Diego · doi:10.7270/q2f76hxn
Metadata
- Authors
- Méndez-Lucio, O., & Medina-Franco, J. L.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 22
- Issue
- 1
- Pages
- 120-126
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2516032265
- Cited by
- 180
- References
- 45
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 32 · 2023: 20 · 2022: 24 · 2021: 20 · 2020: 19 · 2019: 11 · 2018: 11 · 2017: 9
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Social Sciences › Arts and Humanities › History and Philosophy of Science › History and advancements in chemistry
- Keywords
- molecular complexity, complexity measures, drug discovery, target selectivity
- MeSH terms
- Pharmaceutical Preparations, Models, Chemical, Structure-Activity Relationship, Drug Design, Molecular Structure, Databases, Factual, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review